United States Interventional Neuroradiology Market Outlook to 2033 – Neurovascular Embolization Devices, Neurovascular Accessory Devices, Intracranial Stents and Others

All the vital news, analysis, and commentary curated by our industry experts.

$4995

Buy Report

Published: April 27, 2026 Report Code: GDME47174CCDB-ST

Report Overview
Key Players
Table of Contents
Table
Figures

GlobalData’s “United States Interventional Neuroradiology Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Interventional Neuroradiology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Neurovascular Embolization Devices, Neurovascular Accessory Devices, Intracranial Stents, Neurovascular Coiling Assist Devices and Neurovascular Thrombectomy Devices

The United States Interventional Neuroradiology Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2025 company share data for Interventional Neuroradiology Market.
• Global corporate-level profiles of key companies operating within the United States Interventional Neuroradiology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Interventional Neuroradiology is segmented as follows:

• Neurovascular Embolization Devices

• Neurovascular Accessory Devices

• Intracranial Stents

• Neurovascular Coiling Assist Devices

• Neurovascular Thrombectomy Devices

Reasons to Buy

The United States Interventional Neuroradiology Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Stryker Corp
Medtronic Plc
Penumbra Inc
Terumo Neuro
Cerenovus
Imperative Care Inc
Balt SAS
Scientia Vascular LLC
Rapid Medical Ltd
Phenox GmbH

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Interventional Neuroradiology Market Segmentation

2.3 Definitions of Markets Covered in the Report

3 Interventional Neuroradiology Market, United States

3.1 Interventional Neuroradiology Market, United States, Revenue ($m), 2018-2033

3.1.1 Neurovascular Accessory Devices Market, United States, Revenue ($m), by Segment, 2018-2033

3.1.2 Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), by Segment, 2018-2033

3.1.3 Neurovascular Embolization Devices Market, United States, Revenue ($m), by Segment, 2018-2033

3.1.4 Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), by Segment, 2018-2033

3.2 Interventional Neuroradiology Market, United States, Volume (Units), 2018-2033

3.2.1 Neurovascular Accessory Devices Market, United States, Volume (Units), by Segment, 2018-2033

3.2.2 Neurovascular Coiling Assist Devices Market, United States, Volume (Units), by Segment, 2018-2033

3.2.3 Neurovascular Embolization Devices Market, United States, Volume (Units), by Segment, 2018-2033

3.2.4 Neurovascular Thrombectomy Devices Market, United States, Volume (Units), by Segment, 2018-2033

3.3 Interventional Neuroradiology Market, United States, Average Price ($), 2018-2033

3.4 Interventional Neuroradiology Market, United States, Company Share by Revenue ($m), 2025

4 Overview of Key Companies in United States, Interventional Neuroradiology Market

4.1 Stryker Corp

4.1.1 Company Overview

4.2 Medtronic Plc

4.2.1 Company Overview

4.3 Penumbra Inc

4.3.1 Company Overview

4.4 Terumo Neuro

4.4.1 Company Overview

4.5 Cerenovus

4.5.1 Company Overview

4.6 Imperative Care Inc

4.6.1 Company Overview

4.7 Balt SAS

4.7.1 Company Overview

4.8 Scientia Vascular LLC

4.8.1 Company Overview

4.9 Rapid Medical Ltd

4.9.1 Company Overview

4.10 Phenox GmbH

4.10.1 Company Overview

5 Interventional Neuroradiology Market Pipeline Products

6 Recent Developments

6.1 Corporate Communications

6.1.1 Nov 21, 2025: Johnson & Johnson Signs National Charter for Mental Health at Work

6.1.2 Nov 12, 2025: Cabell Huntington Hospital Introduces Siemens Biplane Interventional Radiology System

6.1.3 Oct 30, 2025: 100 Million Gift Advances UCSF’s Dementia Research and Care

6.1.4 Oct 30, 2025: End Brain Cancer Initiative Partners with Exvade Bioscience to Raise Awareness of Brain Cancer Study

6.1.5 Oct 30, 2025: Siddiqui Performs World’s First Robotic Microsurgical Intracranial Brain Surgery

6.1.6 Oct 28, 2025: Kim Kardashian Provides Health Update Following Diagnosis

6.1.7 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed

6.1.8 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio

6.2 Financial Announcements

6.2.1 Jul 01, 2025: Penumbra Schedules Second Quarter 2025 Earnings Release and Conference Call for July 29, 2025

6.2.2 Apr 15, 2025: Johnson & Johnson Announces Q1 2025 Results

6.3 Government and Public Interest

6.3.1 Aug 20, 2025: Penumbra to Present at Upcoming Investor Conferences

6.3.2 Jul 24, 2025: Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference

6.3.3 Apr 16, 2025: Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

6.3.4 Feb 03, 2025: Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference

6.4 Other Significant Developments

6.4.1 Nov 24, 2025: NeuroPace Announces Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services

6.4.2 Oct 24, 2025: Laser Procedure Offers Solutions For Epilepsy And Brain Tumors

6.4.3 Oct 23, 2025: Peking University International Hospital Establishes ZAP-X Radiosurgery Center

6.5 Product News

6.5.1 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV

6.5.2 Nov 21, 2025: Imperative Care Reports Real-World ADAPT

2.0 Data in Ischemic Stroke Patients Using Zoom Stroke System

6.5.3 Nov 18, 2025: QuantalX Receives FDA De Novo Clearance for Delphi-MD

6.5.4 Nov 15, 2025: Evidence Builds for Disrupted Mitochondria as Cause of Parkinson’s

6.5.5 Nov 11, 2025: Sentante Introduces Innovative Remote Robotic Stroke Procedure

6.5.6 Nov 10, 2025: URI Team Develops Tabletop Device to Study Long-Term Effects of Traumatic Brain Injury

6.5.7 Nov 05, 2025: MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients

6.5.8 Oct 30, 2025: Siddiqui Performs World’s First Robotic Microsurgical Intracranial Brain Surgery

6.5.9 Oct 29, 2025: FDA-Approved Focused Ultrasound Treatment for Essential Tremor Now Used for Parkinson's

6.5.10 Oct 14, 2025: NeuroOne Expands Patent Portfolio With Recent USPTO and EPO Decisions

6.5.11 Oct 10, 2025: An International Project Employs 'Resurrected' Ancestral Enzymes for Cancer Prevention and Neurobiology Studies

6.5.12 Oct 06, 2025: MMI Achieves Breakthrough In Robotic Microsurgical Intracranial Brain Surgery

6.5.13 Oct 02, 2025: Karl Storz Begins Neurosurgery Revitalization in Europe

6.5.14 Sep 25, 2025: New Study Highlights Differences in Whole Brain Radiation Exposure Across Radiosurgery Platforms

6.5.15 Sep 23, 2025: FDA Clears Cionic Neural Sleeve 2 For Enhanced Mobility Care

6.6 Research And Development

6.6.1 Oct 10, 2025: An International Project Employs 'Resurrected' Ancestral Enzymes for Cancer Prevention and Neurobiology Studies

6.7 Strategy And Business Planning

6.7.1 Oct 27, 2025: Remedy Robotics And Mission Thrombectomy Partner To Expand Access To Thrombectomy For Stroke

6.7.2 Oct 02, 2025: Karl Storz Begins Neurosurgery Revitalization in Europe

7 Appendix

7.1 Research Methodology

7.1.1 Coverage

7.1.2 Secondary Research

7.1.3 Primary Research

7.1.4 Market Modeling and Forecasting

7.1.5 Company Share Analysis

7.1.6 Benchmarking

7.2 GlobalData Consulting

7.3 Contact Us

7.4 Disclaimer

Table

Table 1: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 2: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 3: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 4: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 5: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2018-2033

Table 6: Interventional Neuroradiology Market, United States, Volume (Units), 2018-2033

Table 7: Neurovascular Accessory Devices Market, United States, Volume (Units), 2018-2033

Table 8: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2018-2033

Table 9: Neurovascular Embolization Devices Market, United States, Volume (Units), 2018-2033

Table 10: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2018-2033

Table 11: Interventional Neuroradiology Market, United States, Average Price ($), 2018-2033

Table 12: Interventional Neuroradiology Market, United States, Company Share by Revenue ($m), 2025

Table 13: Interventional Neuroradiology Market Pipeline Products

Table 14: Total Number of Primary Research Participants, Neurology Devices Market, by Country

Figures

Figure 1: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 2: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 3: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 4: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 5: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2018-2033

Figure 6: Interventional Neuroradiology Market, United States, Volume (Units), 2018-2033

Figure 7: Neurovascular Accessory Devices Market, United States, Volume (Units), 2018-2033

Figure 8: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2018-2033

Figure 9: Neurovascular Embolization Devices Market, United States, Volume (Units), 2018-2033

Figure 10: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2018-2033

Figure 11: Interventional Neuroradiology Market, United States, Company Share (%), 2025

United States Interventional Neuroradiology Market Outlook to 2033 – Neurovascular Embolization Devices, Neurovascular Accessory Devices, Intracranial Stents and Others standard reports

Currency USD

Single User

$4,995

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Neurology Devices reports

Medical Devices

New

Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement,…

Medical Devices

New

Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and…

Medical Devices

New

Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement,…

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States Interventional Neuroradiology Market Outlook to 2033 – Neurovascular Embolization Devices, Neurovascular Accessory Devices, Intracranial Stents and Others in real time.

Access a live United States Interventional Neuroradiology Market Outlook to 2033 – Neurovascular Embolization Devices, Neurovascular Accessory Devices, Intracranial Stents and Others dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

United States Interventional Neuroradiology Market Outlook to 2033 – Neurovascular Embolization Devices, Neurovascular Accessory Devices, Intracranial Stents and Others

Scope

Reasons to Buy

Table of Contents

Table

Figures

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Related reports